SUBSCRIBE
SUBSCRIBE

CNS Pharmaceuticals, Inc.

NEWS
Image of Houston downtown park and skyline in the morning
Business
Houston’s Life Sciences Scene Continues Boosting Its Reputation
While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.
March 13, 2025
 · 
6 min read
 · 
Angela Gabriel
IN THE PRESS
BioMidwest
CNS Announces Highlights from Annual Meeting of Shareholders - June 09, 2020
June 9, 2020
 · 
3 min read
Business
CNS Pharmaceuticals Announces Sponsored Research Agreement with MD Anderson for Potential Cancer Treatment Technologies
May 28, 2020
 · 
4 min read
Deals
CNS Announces Common Stock Will Resume Trading on the NASDAQ on May 28, 2020
May 27, 2020
 · 
3 min read
BioMidwest
CNS Provides Update on Development Agreement for WP1122
May 27, 2020
 · 
6 min read
Deals
CNS Announces Nasdaq Trading Halt Pending Receipt of Additional Information
May 18, 2020
 · 
3 min read
Deals
CNS Provides Additional Comments Regarding Trading Halt
May 11, 2020
 · 
4 min read
Policy
Investor Alert: Kaplan Fox Investigates CNS Pharmaceuticals
May 8, 2020
 · 
1 min read
Job Trends
CNS Pharmaceuticals Announces Trading Halt
May 4, 2020
 · 
4 min read
Business
CNS Pharmaceuticals and WPD Pharmaceuticals Identify Leading Polish Medical Institutions for Berubicin Phase 2 Clinical Trial
April 30, 2020
 · 
5 min read
Lone Star Bio
CNS Pharmaceuticals Announces Filing of FDA Orphan Drug Designation for Brain Cancer Drug Berubicin
April 23, 2020
 · 
5 min read
Load More
JOBS